BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 30223932)

  • 1. Effects of the antiretroviral drug 2'-deoxy-2'-β-fluoro-4'-azidocytidine (FNC) on P-gp, MRP2 and BCRP expressions and functions.
    Liu Y; Wang Y; Peng Y; Liu B; Ma F; Jiang J; Wang Q; Chang J
    Pharmazie; 2018 Sep; 73(9):503-507. PubMed ID: 30223932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prandial state and biological sex modulate clinically relevant efflux transporters to different extents in Wistar and Sprague Dawley rats.
    Gavins FKH; Dou L; Qin Y; Madla CM; Murdan S; Basit AW; Mai Y; Orlu M
    Biomed Pharmacother; 2023 Apr; 160():114329. PubMed ID: 36731343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black ginger extract and its active compound, 5,7-dimethoxyflavone, increase intestinal drug absorption via efflux drug transporter inhibitions.
    Boonnop R; Meetam P; Siangjong L; Tuchinda P; Thongphasuk P; Soodvilai S; Soodvilai S
    Drug Metab Pharmacokinet; 2023 Jun; 50():100500. PubMed ID: 36948091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
    PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Evaluation of P-gp and Bcrp at the Murine Blood-Cerebrospinal Fluid Barrier.
    Sun A; Wang J
    Pharm Res; 2023 Nov; 40(11):2667-2675. PubMed ID: 37704894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 at the Blood-Brain Barrier.
    Cannon RE; Richards AC; Trexler AW; Juberg CT; Sinha B; Knudsen GA; Birnbaum LS
    Environ Health Perspect; 2020 Mar; 128(3):37002. PubMed ID: 32212926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDR1 and BCRP Transporter-Mediated Drug-Drug Interaction between Rilpivirine and Abacavir and Effect on Intestinal Absorption.
    Reznicek J; Ceckova M; Ptackova Z; Martinec O; Tupova L; Cerveny L; Staud F
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and Fetal Exposure to (-)-Δ
    Chen X; Unadkat JD; Mao Q
    Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein-Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo.
    Zhang Y; Shipkova PA; Warrack BM; Nelson DM; Wang L; Huo R; Chen J; Panfen E; Chen XQ; Fancher RM; Ruan Q; Christopher LJ; Xue Y; Sinz M; Shen H
    Drug Metab Dispos; 2023 Jul; 51(7):851-861. PubMed ID: 37055191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular Metabolomics Identifies Efflux Transporter Inhibitors in a Routine Caco-2 Cell Permeability Assay-Biological Implications.
    Naseem A; Pal A; Gowan S; Asad Y; Donovan A; Temesszentandrási-Ambrus C; Kis E; Gaborik Z; Bhalay G; Raynaud F
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis and Biological Evaluation of Quinazolinamine Derivatives as Breast Cancer Resistance Protein and P-Glycoprotein Inhibitors with Improved Metabolic Stability.
    Cai CY; Teng QX; Murakami M; Ambudkar SV; Chen ZS; Korlipara VL
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Danofloxacin-mesylate is a substrate for ATP-dependent efflux transporters.
    Schrickx JA; Fink-Gremmels J
    Br J Pharmacol; 2007 Feb; 150(4):463-9. PubMed ID: 17211460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in mice.
    Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
    Pharmacol Res Perspect; 2020 Feb; 8(1):e00544. PubMed ID: 31988753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.
    Chu J; Panfen E; Wang L; Marino A; Chen XQ; Fancher RM; Landage R; Patil O; Desai SD; Shah D; Xue Y; Sinz M; Shen H
    Pharm Res; 2023 Nov; 40(11):2567-2584. PubMed ID: 37523014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaempferol suppression of acute colitis is regulated by the efflux transporters BCRP and MRP2.
    Liu Y; Lu Y; Li X; Zhang Z; Sun L; Wang Y; He Z; Liu Z; Zhu L; Fu L
    Eur J Pharm Sci; 2022 Dec; 179():106303. PubMed ID: 36252521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transporter and metabolic enzyme-mediated intra-enteric circulation of SN-38, an active metabolite of irinotecan: A new concept.
    Martha L; Nakata A; Furuya S; Liu W; Zhang X; Mizoi K; Ogihara T
    Biochem Biophys Res Commun; 2023 Jul; 665():19-25. PubMed ID: 37148742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of P-glycoprotein and Breast Cancer Resistance Protein Expression Induced by Focused Ultrasound-Mediated Blood-Brain Barrier Disruption: A Pilot Study.
    Conti A; Geffroy F; Kamimura HAS; Novell A; Tournier N; Mériaux S; Larrat B
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uptake and transport of Laportea bulbifera extract in Caco-2 cell model].
    Huang J; Xiao HQ; Li Y; Chen Y; Chen SY; Li YT; Huang Y; Zheng L; Wang YL; Gong ZP
    Zhongguo Zhong Yao Za Zhi; 2022 Oct; 47(20):5617-5626. PubMed ID: 36471980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Prediction of Fetal Exposure to Dual BCRP/P-gp Drug Substrates Using the Efflux Ratio-Relative Expression Factor Approach and PBPK M&S.
    Balhara A; Yin M; Unadkat JD
    Clin Pharmacol Ther; 2024 May; 115(5):1044-1053. PubMed ID: 38124355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Screening System for Biliary Excretion of Drugs Using Human Cholangiocyte Organoid Monolayers with Directional Drug Transport.
    Mizoi K; Okada R; Mashimo A; Masuda N; Itoh M; Ishida S; Yamazaki D; Ogihara T
    Biol Pharm Bull; 2024; 47(2):427-433. PubMed ID: 38369341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.